CRSP icon

CRISPR Therapeutics

434 hedge funds and large institutions have $3.7B invested in CRISPR Therapeutics in 2022 Q3 according to their latest regulatory filings, with 58 funds opening new positions, 129 increasing their positions, 115 reducing their positions, and 50 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
434
Holders Change
+1
Holders Change %
+0.23%
% of All Funds
7.5%
Holding in Top 10
8
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+60%
% of All Funds
0.14%
New
58
Increased
129
Reduced
115
Closed
50
Calls
$223M
Puts
$213M
Net Calls
+$10.5M
Net Calls Change
+$83K
Name Holding Trade Value Shares
Change
Shares
Change %
GI
401
Gradient Investments
Minnesota
$2K
ME
402
McIlrath & Eck
Washington
$2K
GWSG
403
GPS Wealth Strategies Group
Colorado
$2K
KA
404
Kozak & Associates
Colorado
$2K
SIC
405
SJS Investment Consulting
Ohio
$2K +$2K +34 New
CMBA
406
C.M. Bidwell & Associates
Hawaii
$1K -$1.94K -35 -66%
LC
407
Lindbrook Capital
California
$1K -$1.18K -20 -54%
HS
408
Horan Securities
United States
$1K
IFAM
409
Institutional & Family Asset Management
Colorado
$1K
TFS
410
TrustCore Financial Services
Tennessee
$1K
KFI
411
Key Financial Inc
Pennsylvania
$1K
SWA
412
SOA Wealth Advisors
New York
$1K
CMP
413
Coston McIsaac & Partners
Maine
$1K
CFB
414
Cullen/Frost Bankers
Texas
$1K
CFD
415
Creative Financial Designs
Indiana
$1K
TFM
416
TFC Financial Management
Massachusetts
$1K
CFFP
417
Center for Financial Planning
Michigan
$1K
NMG
418
New Millennium Group
Utah
$1K
NSIM
419
North Star Investment Management
Illinois
$1K
DSC
420
Duncker Streett & Co
Missouri
$1K
MIM
421
Macroview Investment Management
Maryland
$1K
JWM
422
Janiczek Wealth Management
Colorado
$1K
SWM
423
Sugarloaf Wealth Management
Georgia
$1K
CSB
424
City State Bank
Iowa
$1K
FWA
425
FSC Wealth Advisors
New York
$1K